Cost-effectiveness of everolimus-eluting versus bare-metal stents in ST-segment elevation myocardial infarction: An analysis from the EXAMINATION randomized controlled trial - Wikidata - awgldk - TriplyDB

Cost-effectiveness of everolimus-eluting versus bare-metal stents in ST-segment elevation myocardial infarction: An analysis from the EXAMINATION randomized controlled trial

Cost-effectiveness of everolimus-eluting versus bare-metal stents in ST-segment elevation myocardial infarction: An analysis from the EXAMINATION randomized controlled trial

http://www.wikidata.org/entity/Q58775093

about

Cost-effectiveness of everolimus-eluting versus bare-metal stents in ST-segment elevation myocardial infarction: An analysis from the EXAMINATION randomized controlled trial

http://www.wikidata.org/entity/Q58775093

description

article publié dans la revue scientifique PLoS ONE

@fr

im Januar 2018 veröffentlichter wissenschaftlicher Artikel

@de

scientific article published in PLoS ONE

@en

wetenschappelijk artikel

@nl

наукова стаття, опублікована у 2018

@uk

name

Cost-effectiveness of everolim ...... ON randomized controlled trial

@en

Cost-effectiveness of everolim ...... ON randomized controlled trial

@nl

type

label

Cost-effectiveness of everolim ...... ON randomized controlled trial

@en

Cost-effectiveness of everolim ...... ON randomized controlled trial

@nl

prefLabel

Cost-effectiveness of everolim ...... ON randomized controlled trial

@en

Cost-effectiveness of everolim ...... ON randomized controlled trial

@nl

P1433

Q58775093-A384B120-CA5B-43F7-B6DA-3527C624B1E5

P1476

Q58775093-FF15B7EF-11D5-4644-BE36-4EE1A0C19837

P2093

Q58775093-091ECC2F-0F5B-40D0-8A44-129A8FFFF509

Q58775093-09E36F4B-1133-494D-9500-1BCDC72F34A5

Q58775093-3697EF46-7565-4458-8305-A22081EB366C

Q58775093-466CCDC0-3C0F-422C-AF16-58FD56E2921D

Q58775093-4E46661D-2A83-4101-B327-B78E80E5B119

Q58775093-5C794128-7773-4E14-9EC9-535F939146DF

Q58775093-728F4E94-92E8-4830-AF53-6F668D68B15B

Q58775093-A6F16E0F-0329-49C5-848B-FD8FA7B6B85A

Q58775093-AD07C1A1-F707-4860-9444-5D56A80216FA

Q58775093-BAA53FB8-28C5-44FE-94C6-1CE39BD97EC2

P2860

Q58775093-11293F57-0CAD-4FA0-BC0D-A5F7C7633BA7

Q58775093-1D3DF162-1559-422C-BDB0-B6F59B871134

Q58775093-1E097F53-6A0B-4F4A-A352-F1603B8A45A6

Q58775093-291A77F9-0C0E-4412-8673-1813584400AE

Q58775093-3B7DEC3B-5746-4364-8442-B79CFC7A5D44

Q58775093-45CE4969-E95E-4478-91D2-4D04D6353B89

Q58775093-58390C20-1D55-4B67-B517-64B577888D88

Q58775093-711F0A3C-2C6B-4E91-A332-C73F2A7ECC80

Q58775093-79B15114-0E2F-4934-BA19-B49A9DA7ADA1

Q58775093-80374FCE-9F71-4459-86E5-75C34C4C73D2

P304

Q58775093-348A9D35-19C4-49F0-9435-102C2F9EB8BE

P31

Q58775093-269991D2-B3F2-4EDB-85E3-4A1534078E81

P356

Q58775093-F694B034-9585-4A1E-A876-7FAE854CE22A

P407

Q58775093-97956999-4186-4C1C-A431-5C59CC9B83CE

P433

Q58775093-9FF9C523-B95E-4A13-8B6D-98345CABCC4F

P478

Q58775093-E52581B5-2802-415F-B66D-67F4BB94A228

P50

Q58775093-3A119178-E57B-430F-A4CD-FEE3274E3D35

Q58775093-7C5D1A3E-929B-4517-AD43-C96F8C801EAA

Q58775093-9341A2C8-6476-4046-9D56-243D4B6F5300

Q58775093-E9471624-DC4E-4DA1-A5DA-1550F5F7F6B8

P577

Q58775093-36DCA818-F9A7-4AA1-A9B6-95219A1F11F1

P698

Q58775093-83E1B94C-08A6-4767-8B2F-D73194A6804C

P932

Q58775093-DB494BA6-946E-4D8D-A74A-744383D0414F

P356

JOURNAL.PONE.0201985

P1433

P1476

Cost-effectiveness of everolim ...... ON randomized controlled trial

@en

P2093

Andrés Iñiguez

http://www.w3.org/2001/XMLSchema#string

Angel Cequier

http://www.w3.org/2001/XMLSchema#string

Antonio Serra

http://www.w3.org/2001/XMLSchema#string

Armando Bethencourt

http://www.w3.org/2001/XMLSchema#string

Gianluca Campo

http://www.w3.org/2001/XMLSchema#string

Marco Valgimigli

http://www.w3.org/2001/XMLSchema#string

Maurizio Tespili

http://www.w3.org/2001/XMLSchema#string

Nicolás Vazquez

http://www.w3.org/2001/XMLSchema#string

Patrick W Serruys

http://www.w3.org/2001/XMLSchema#string

Peter den Heijer

http://www.w3.org/2001/XMLSchema#string

P2860

Generalized cost-effectiveness analysis for national-level priority-setting in the health sector

Epidemiology of coronary heart disease and acute coronary syndrome

Life Expectancy and Years of Potential Life Lost After Acute Myocardial Infarction by Sex and Race: A Cohort-Based Study of Medicare Beneficiaries.

Continuing inequality: gender and social class influences on self perceived health after a heart attack.

ST Elevation Myocardial Infarction in the elderly

Percutaneous coronary intervention with second-generation drug-eluting stent versus bare-metal stent: Systematic review and cost-benefit analysis

Clinical end points in coronary stent trials: a case for standardized definitions.

The NICE cost-effectiveness threshold: what it is and what that means.

Cost-effectiveness of percutaneous coronary intervention with cobalt-chromium everolimus eluting stents versus bare metal stents: Results from a patient level meta-analysis of randomized trials.

Clinical outcomes in patients with ST-segment elevation myocardial infarction treated with everolimus-eluting stents versus bare-metal stents (EXAMINATION): 5-year results of a randomised trial.

P304

e0201985

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0201985

http://www.w3.org/2001/XMLSchema#string

P407

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

13

http://www.w3.org/2001/XMLSchema#string

P50

Matthias Schwenkglenks

P577

2018-08-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

30114230

http://www.w3.org/2001/XMLSchema#string

P932

6095536

http://www.w3.org/2001/XMLSchema#string